Genomics & Genetics Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genomics & Genetics Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Virotherapy-mediated hepatotoxicity studied in liver tissue
July 14th, 2006
Recent research from the United States published in the journal Cancer Gene Therapy has chronicled the use of liver tissue slice analysis to assay hepatotoxicity linked to replicative and nonreplicative adenoviral agents. "Whereas virotherapy has emerged as a novel and promising approach for neoplastic diseases, appropriate model systems have hampered preclinical evaluation of candidate conditionally replicative adenovirus agents (CRAds) with respect to liver toxicity. This is due to the inability of human viral agents to cross species. "We have recently shown the human liver tissue slice model to be a facile means to validate adenoviral...
Source: Genomics & Genetics Weekly (2006-07-14)
|
